IDT Australia Limited has announced the acquisition of 23 generic drugs from the Global Generics Company. The purchase was made for a total of $14.8 million dollars. Among the drugs purchased are treatments for depression, Parkinson’s, hypertension, and pain management, among others. IDT is looking to immediately begin manufacturing the newly acquired drugs at the company’s Melbourne manufacturing facility. IDT had wanted to strengthen its generics portfolio.